chr2-72888532-G-A
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_003124.5(SPR):c.523G>A(p.Ala175Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000187 in 1,604,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A175D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003124.5 missense
Scores
Clinical Significance
Conservation
Publications
- dopa-responsive dystonia due to sepiapterin reductase deficiencyInheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, G2P, Ambry Genetics
- BH4-deficient hyperphenylalaninemia AInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPR | ENST00000234454.6 | c.523G>A | p.Ala175Thr | missense_variant | Exon 2 of 3 | 1 | NM_003124.5 | ENSP00000234454.5 | ||
| SPR | ENST00000498749.2 | n.*105G>A | non_coding_transcript_exon_variant | Exon 2 of 3 | 3 | ENSP00000519026.1 | ||||
| SPR | ENST00000498749.2 | n.*105G>A | 3_prime_UTR_variant | Exon 2 of 3 | 3 | ENSP00000519026.1 | ||||
| SPR | ENST00000713723.1 | c.304+796G>A | intron_variant | Intron 1 of 1 | ENSP00000519027.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000411 AC: 1AN: 243094 AF XY: 0.00000763 show subpopulations
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452362Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 721380 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74350 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Dystonic disorder Uncertain:1
This sequence change replaces alanine with threonine at codon 175 of the SPR protein (p.Ala175Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SPR-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at